Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
US9402825B2 · kind B2 · utility
6Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2014 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | Jul 10, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Dry powder formulations for inhalation comprising a combination of an anticholinergic, a long-acting beta2-adrenoceptor agonist, and a corticosteroid are useful for the prevention and/or treatment of inflammatory and/or obstructive airways diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.